Immunological axis of curcumin-loaded vesicular drug delivery systems.

Several vesicular systems loaded with curcumin have found their way in the therapeutic applications of several diseases, primarily acting through their immunological pathways. Such systems use particles at a nanoscale range, bringing about their intended use through a range of complex mechanisms. Apart from delivering drug substances into target tissues, these vesicular systems also effectively overcome problems like insolubility and unequal drug distribution. Several mechanisms are explored lately by different workers, and interest over vesicular curcumin has been renewed in the past decade. This commentary discusses several immunological targets in which curcumin is employed in a vesicular form.

[1]  K. Dua,et al.  Recent Advances in Oncological Submissions of Dendrimer. , 2017, Current pharmaceutical design.

[2]  Ling Liu,et al.  Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF‐κB signaling pathway , 2017, Influenza and other respiratory viruses.

[3]  V. Velu,et al.  Evaluation of in vitro and in vivo anti-urolithiatic activity of silver nanoparticles containing aqueous leaf extract of Tragia involucrata , 2017, Drug Delivery and Translational Research.

[4]  M. Djalali,et al.  The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients , 2017, Immunogenetics.

[5]  P. Birembaut,et al.  Evaluation of intracavitary administration of curcumin for the treatment of sarcomatoid mesothelioma , 2017, Oncotarget.

[6]  H. Momeni,et al.  Effect of curcumin on kidney histopathological changes, lipid peroxidation and total antioxidant capacity of serum in sodium arsenite-treated mice. , 2017, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[7]  G. Steiner,et al.  In Vitro Study of a Liposomal Curcumin Formulation (Lipocurc™): Toxicity and Biological Activity in Synovial Fibroblasts and Macrophages. , 2016, In vivo.

[8]  N. Shastri,et al.  Emu oil based nano-emulgel for topical delivery of curcumin. , 2016, International journal of pharmaceutics.

[9]  K. Dua,et al.  Formulation and evaluation of proniosomes containing lornoxicam , 2016, Drug Delivery and Translational Research.

[10]  D. Ghosh,et al.  Vesicular (liposomal and nanoparticulated) delivery of curcumin: a comparative study on carbon tetrachloride–mediated oxidative hepatocellular damage in rat model , 2016, International journal of nanomedicine.

[11]  N. Chauhan,et al.  Curcumin Nanoformulation for Cervical Cancer Treatment , 2016, Scientific Reports.

[12]  A. Kumari,et al.  Lipopolysaccharide (LPS) exposure differently affects allergic asthma exacerbations and its amelioration by intranasal curcumin in mice. , 2015, Cytokine.

[13]  F. Najafi,et al.  Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair , 2015, Neuropharmacology.

[14]  Sharmistha Banerjee,et al.  The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[15]  K. Chopra,et al.  Curcumin loaded solid lipid nanoparticles ameliorate adjuvant‐induced arthritis in rats , 2015, European journal of pain.

[16]  M. Forte,et al.  Curcumin loaded PLGA-poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  R. Mason,et al.  Fabrication of Curcumin Micellar Nanoparticles with Enhanced Anti-Cancer Activity. , 2015, Journal of biomedical nanotechnology.

[18]  F. Sarkar,et al.  Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells , 2015, Oncotarget.

[19]  B. Baradaran,et al.  Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing m1/m2 macrophage balance in the tumor microenvironment. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[20]  Xiao-hua Han,et al.  Curcumin ameliorates asthmatic airway inflammation by activating nuclear factor‐E2‐related factor 2/haem oxygenase (HO)‐1 signalling pathway , 2015, Clinical and experimental pharmacology & physiology.

[21]  N. Schizas,et al.  Potential anticancer properties and mechanisms of action of curcumin. , 2015, Anticancer research.

[22]  Yu Cao,et al.  Oral Administration of Nano-Emulsion Curcumin in Mice Suppresses Inflammatory-Induced NFκB Signaling and Macrophage Migration , 2014, PloS one.

[23]  Lingli Li,et al.  Preparation of curcumin micelles and the in vitro and in vivo evaluation for cancer therapy. , 2014, Journal of biomedical nanotechnology.

[24]  K. Dua,et al.  Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery , 2014, International journal of pharmaceutical investigation.

[25]  P. Gupta,et al.  Enhancement of phototoxicity of curcumin in human oral cancer cells using silica nanoparticles as delivery vehicle , 2014, Lasers in Medical Science.

[26]  Subhashini,et al.  Intranasal curcumin and its evaluation in murine model of asthma. , 2013, International immunopharmacology.

[27]  Dinesh Kumar,et al.  Formulation, characterization, in vitro, in vivo, and histopathological evaluation of transdermal drug delivery containing norfloxacin and Curcuma longa , 2013, International journal of pharmaceutical investigation.

[28]  J. Vishwanatha,et al.  Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis. , 2013, Anticancer research.

[29]  A. Bansal,et al.  SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[30]  R. Mason,et al.  Curcumin and its Derivatives: Their Application in Neuropharmacology and Neuroscience in the 21st Century , 2013, Current neuropharmacology.

[31]  Wendy van de Luijtgaarden,et al.  Nano-Curcumin Inhibits Proliferation of Esophageal Adenocarcinoma Cells and Enhances the T Cell Mediated Immune Response , 2013, Front. Oncol..

[32]  N. Rogers,et al.  Amelioration of renal ischaemia–reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen‐presenting cells , 2012, British journal of pharmacology.

[33]  B. Aggarwal,et al.  Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials , 2012, The AAPS Journal.

[34]  Raju C Reddy,et al.  Curcumin-Loaded Apotransferrin Nanoparticles Provide Efficient Cellular Uptake and Effectively Inhibit HIV-1 Replication In Vitro , 2011, PloS one.

[35]  C. Mohanty,et al.  The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. , 2010, Biomaterials.

[36]  R. Orlando,et al.  Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes , 2008, Nutrition & metabolism.